Literature DB >> 33442340

Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells.

Sarah Cunningham1, Holger Hackstein1.   

Abstract

Dendritic cells (DCs) are pivotal regulators of immune responses, specialized in antigen presentation and bridging the gap between the innate and adaptive immune system. Due to these key features, DCs have become a pillar of the continuously growing field of cellular therapies. Here we review recent advances in good manufacturing practice strategies and their individual specificities in relation to DC production for clinical applications. These take into account both small-scale experimental approaches as well as automated systems for patient care.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Dendritic cells; Good manufacturing practice; Monocytes

Year:  2020        PMID: 33442340      PMCID: PMC7768120          DOI: 10.1159/000512451

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  103 in total

Review 1.  RANTES: a versatile and controversial chemokine.

Authors:  V Appay; S L Rowland-Jones
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

2.  Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy.

Authors:  Yiming Meng; Jing Sun; Tingting Hu; Yushu Ma; Tiaozhao Du; Cuicui Kong; Guirong Zhang; Tao Yu; Haozhe Piao
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

3.  Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes.

Authors:  T Matsunaga; T Ishida; M Takekawa; S Nishimura; M Adachi; K Imai
Journal:  Scand J Immunol       Date:  2002-12       Impact factor: 3.487

4.  Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow.

Authors:  Andreas Schlitzer; V Sivakamasundari; Jinmiao Chen; Hermi Rizal Bin Sumatoh; Jaring Schreuder; Josephine Lum; Benoit Malleret; Sanqian Zhang; Anis Larbi; Francesca Zolezzi; Laurent Renia; Michael Poidinger; Shalin Naik; Evan W Newell; Paul Robson; Florent Ginhoux
Journal:  Nat Immunol       Date:  2015-06-08       Impact factor: 25.606

5.  siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.

Authors:  Willemijn Hobo; Frans Maas; Niken Adisty; Theo de Witte; Nicolaas Schaap; Robbert van der Voort; Harry Dolstra
Journal:  Blood       Date:  2010-08-03       Impact factor: 22.113

6.  9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development.

Authors:  Fernando Zapata-Gonzalez; Félix Rueda; Jordi Petriz; Pere Domingo; Francesc Villarroya; Africa de Madariaga; Joan C Domingo
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

7.  Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function.

Authors:  Mirjana Fogel-Petrovic; Julie A Long; Neil L Misso; Paul S Foster; Kanti D Bhoola; Philip J Thompson
Journal:  Int Immunopharmacol       Date:  2007-07-31       Impact factor: 4.932

8.  Adhesion-mediating molecules of human monocytes.

Authors:  M Patarroyo; J Prieto; P G Beatty; E A Clark; C G Gahmberg
Journal:  Cell Immunol       Date:  1988-05       Impact factor: 4.868

9.  Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.

Authors:  Boris Fedoric; Ravi Krishnan
Journal:  Immunol Lett       Date:  2008-07-22       Impact factor: 3.685

Review 10.  Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results.

Authors:  Beatris Mastelic-Gavillet; Klara Balint; Caroline Boudousquie; Philippe O Gannon; Lana E Kandalaft
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

View more
  2 in total

1.  Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.

Authors:  Tadej Fevžer; Primož Poženel; Kaja Zajc; Nataša Tešić; Urban Švajger
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

Review 2.  Cord-Blood-Derived Professional Antigen-Presenting Cells: Functions and Applications in Current and Prospective Cell Therapies.

Authors:  Sarah Cunningham; Holger Hackstein
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.